Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZKY001 for Corneal Epithelial Defects After Endothelial Transplantation
NCT04228926Phase 2Unknown
- Sponsor
- Zhaoke Ophthalmology
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of germinal peptide in Corneal epithelial defect, sponsored by Zhaoke Ophthalmology. Status: unknown.
02
Drugs
germinal peptide
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on NCT04228926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04228926.